Shivinder Singh's charges against brother and former Religare CEO Sunil Godhwani

Shivinder Singh's charges against brother and former Religare CEO Sunil Godhwani

In his petition before the National Company Law Tribunal in New Delhi, Shivinder has leveled the following charges against elder brother Malvinder and former Religare CEO Sunil Godhwani.

Advertisement
BusinessToday.In
  • Sep 5, 2018,
  • Updated Sep 6, 2018 9:32 AM IST

In his petition before the National Company Law Tribunal in New Delhi, Shivinder Singh has leveled the following charges against elder brother Malvinder Singh and former Religare CEO Sunil Godhwani:

"I can no longer be party to activities in which transparency and ethics are continuously and consistently negated."

Advertisement

Shivinder concludes that he is disassociating from Malvinder as a business partner and that he will be pursuing an independent path for himself.

Flash back to 2008 when right after the sale of India's largest pharma firm, Ranbaxy Laboratories to Japan's Daiichi-Sankyo, the brothers were loaded with nearly Rs 10,000 crore in cash. By 2018, they were in debt of Rs 13,000 crore. How they squandered Rs 22,500 crore, lost control of prized possessions such as Fortis Healthcare, once the country's largest hospital chain, and one of the largest NBFCs Religare Enterprises - all in a span of less than a decade has been a subject of business chatter. (Here's how it happened: The Baba, Singh Brothers and the Squandered Rs 225,00,00,00,000)

Advertisement

Interestingly, just last week the brothers had issued a joint statement which blamed former Religare CEO Sunil Godhwani for allegedly orchestrating transactions that left them with a 'debt load'.

In his petition before the National Company Law Tribunal in New Delhi, Shivinder Singh has leveled the following charges against elder brother Malvinder Singh and former Religare CEO Sunil Godhwani:

"I can no longer be party to activities in which transparency and ethics are continuously and consistently negated."

Advertisement

Shivinder concludes that he is disassociating from Malvinder as a business partner and that he will be pursuing an independent path for himself.

Flash back to 2008 when right after the sale of India's largest pharma firm, Ranbaxy Laboratories to Japan's Daiichi-Sankyo, the brothers were loaded with nearly Rs 10,000 crore in cash. By 2018, they were in debt of Rs 13,000 crore. How they squandered Rs 22,500 crore, lost control of prized possessions such as Fortis Healthcare, once the country's largest hospital chain, and one of the largest NBFCs Religare Enterprises - all in a span of less than a decade has been a subject of business chatter. (Here's how it happened: The Baba, Singh Brothers and the Squandered Rs 225,00,00,00,000)

Advertisement

Interestingly, just last week the brothers had issued a joint statement which blamed former Religare CEO Sunil Godhwani for allegedly orchestrating transactions that left them with a 'debt load'.

Read more!
Advertisement